[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-roivant-sciences-stock-rally-mosliciguat-phase-2-results-FR":150},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[],{"post":151,"seo":187,"relatedPosts":193,"suggestedPosts":270},{"id":152,"title":153,"date":154,"modified":155,"excerpt":156,"content":157,"wordCount":158,"lang":159,"uri":160,"slug":161,"cloudinaryAssetId":162,"featuredImageOriginalUrl":163,"featuredImageMetadata":164,"author":167,"editor":173,"categories":178,"relatedPosts":184,"seo":185},129565,"L'action Roivant Sciences progresse de 20 % suite aux résultats positifs de l'essai de phase 2 pour le médicament Pulmovant","2026-09-09T10:53:00","2026-09-09T08:43:17","\u003Cp>L'action de Roivant Sciences bondit de 22 % après des données positives de Phase 2 pour le mosliciguat dans la PH-ILD, alors que le recrutement pour l'essai de Phase 3 commence.\u003C\u002Fp>","\u003Ch2 id=\"h-k-ey-stats-for-roivant-sciences-stock\" class=\"wp-block-heading\">Statistiques \u003Cstrong>clés\u003C\u002Fstrong> pour l'action Roivant Sciences\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Variation du cours de l'action Roivant Sciences sur les 6 derniers mois :\u003C\u002Fstrong> 40%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Cours de l'action $ROIV au 8 septembre :\u003C\u002Fstrong> $41\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Plus haut sur 52 semaines :\u003C\u002Fstrong> $43\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Objectif de cours pour l'action $ROIV : \u003C\u002Fstrong>$42\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Désormais disponible : Découvrez le potentiel de hausse de vos actions préférées grâce au nouveau Modèle de Valorisation de TIKR (C'est gratuit)\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">>>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-what-happened\" class=\"wp-block-heading\">Que s'est-il passé ?\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">L'action Roivant Sciences (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fmultiples?cid=282015801&tid=1675341553&tab=street&ref=49x9sy\">ROIV\u003C\u002Fa>) a bondi de 22% en pré-ouverture après des nouvelles véritablement excitantes concernant un essai clinique. À la clôture, l'action avait gagné 19%.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">La \u003Ca href=\"https:\u002F\u002Ffinance.yahoo.com\u002Fhealthcare\u002Farticles\u002Froivant-sciences-shares-rise-phase-105546820.html\">filiale Pulmovant de la société a dévoilé les résultats principaux d'une étude de Phase 2 nommée PHocus\u003C\u002Fa>, qui testait un médicament appelé mosliciguat chez des patients souffrant d'une affection pulmonaire grave appelée PH-ILD.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Cela signifie hypertension artérielle pulmonaire associée à une maladie pulmonaire interstitielle, une affection progressive où la pression artérielle dans les poumons augmente en raison d'une maladie pulmonaire sous-jacente. Un professeur de l'Université Paris-Saclay a présenté les résultats lors d'une importante conférence médicale européenne.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Le mosliciguat lui-même est un médicament inhalé conçu pour activer une voie enzymatique spécifique, et il est testé comme option thérapeutique potentielle pour les patients atteints de PH-ILD qui n'ont actuellement pas beaucoup de bons choix.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Parallèlement à l'annonce de la Phase 2, Roivant a déclaré avoir déjà lancé une étude de Phase 3 appelée PHrontier pour le même médicament, et qu'elle recrute désormais des patients.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Le passage direct à un essai de Phase 3 témoigne d'une réelle confiance dans les données antérieures, même si l'annonce n'incluait pas de chiffres spécifiques sur l'efficacité et l'innocuité.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Roivant a également organisé une conférence téléphonique pour les investisseurs le même matin afin de détailler plus en profondeur les résultats.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3024\" height=\"2016\" data-public-id=\"images\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3024,h_2016,c_scale\u002Ff_webp,q_auto\u002Fv1788936007\u002Fimages\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6.webp?_i=AA\" alt=\"\" class=\"wp-post-129565 wp-image-129583\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1788936007\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1788936007\u002Fimages\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6.webp?_i=AA 3024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1788936007\u002Fimages\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6.webp?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_800,c_scale\u002Ff_webp,q_auto\u002Fv1788936007\u002Fimages\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_933,c_scale\u002Ff_webp,q_auto\u002Fv1788936007\u002Fimages\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6.webp?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_200,c_scale\u002Ff_webp,q_auto\u002Fv1788936007\u002Fimages\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6\u002FTIKR.com_ROIV-Roivant-Sciences-Ltd_129583aecc6.webp?_i=AA 300w\" sizes=\"auto, (max-width: 3024px) 100vw, 3024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Estimations du chiffre d'affaires, de l'EBIT et du flux de trésorerie disponible de l'action en milliards USD (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">TIKR\u003C\u002Fa>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Ce n'est pas la seule bonne nouvelle récente pour l'action Roivant Sciences.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Quelques semaines plus tôt, fin août, la filiale Priovant de la société a obtenu l'approbation de la FDA pour un médicament appelé LISRAYA, également connu sous le nom de brepocitinib, pour traiter la dermatomyosite, une maladie inflammatoire grave.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Roivant opère via une poignée de filiales, chacune se concentrant sur différents domaines comme les maladies pulmonaires et auto-immunes, donc deux nouvelles positives rapprochées donnent un réel élan à l'action.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>\u003Ca style=\"font-weight: bold; font-style: italic;\" href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Voir les prévisions de croissance et les objectifs de cours des analystes pour l'action Roivant Sciences (C'est gratuit) >>>\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-what-the-market-is-telling-us-about-roivant-sciences-stock\" class=\"wp-block-heading\">Ce que le marché nous dit sur l'action Roivant Sciences\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Le mouvement d'aujourd'hui a propulsé l'action Roivant Sciences au-dessus de son précédent plus haut sur 52 semaines, suggérant que les investisseurs voient cela comme plus qu'une simple mise à jour d'essai de routine.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Le marché au sens large ne bougeait pas beaucoup aujourd'hui. Le Nasdaq était à peu près stable, tandis que le S&P 500 et le Dow Jones étaient tous deux légèrement en baisse.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Cela montre clairement que cette hausse concerne spécifiquement Roivant, et non une tendance de marché plus large qui porterait les actions biotech en général.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full is-resized\">\u003Cimg width=\"737\" height=\"402\" data-public-id=\"images\u002FROIV-stock-street-target_129585cc7ea\u002FROIV-stock-street-target_129585cc7ea.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_737,h_402,c_scale\u002Ff_webp,q_auto\u002Fv1788936055\u002Fimages\u002FROIV-stock-street-target_129585cc7ea\u002FROIV-stock-street-target_129585cc7ea.webp?_i=AA\" alt=\"\" class=\"wp-post-129565 wp-image-129585\" style=\"width:737px;height:auto\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1788936055\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1788936055\u002Fimages\u002FROIV-stock-street-target_129585cc7ea\u002FROIV-stock-street-target_129585cc7ea.webp?_i=AA 737w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_164,c_scale\u002Ff_webp,q_auto\u002Fv1788936055\u002Fimages\u002FROIV-stock-street-target_129585cc7ea\u002FROIV-stock-street-target_129585cc7ea.webp?_i=AA 300w\" sizes=\"auto, (max-width: 737px) 100vw, 737px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Objectif de cours consensus pour l'action ROIV (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">TIKR\u003C\u002Fa>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Le mosliciguat est toujours un médicament expérimental, ce qui signifie qu'il n'a pas encore été approuvé, et il devra réussir l'essai de Phase 3 en cours ainsi que l'examen réglementaire avant de pouvoir être disponible pour les patients.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Néanmoins, le passage direct des données de Phase 2 au recrutement pour la Phase 3 montre que Roivant considère ce programme comme prioritaire.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Combinée à l'approbation récente du LISRAYA, l'action Roivant Sciences bénéficie d'un pipeline qui livre des résultats concrets maintenant, et non pas seulement des promesses pour des années à venir.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Estimez la juste valeur d'une entreprise instantanément (Gratuit avec TIKR) >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-how-much-upside-does-roivant-sciences-stock-have-from-here\" class=\"wp-block-heading\">Quel est le potentiel de hausse de l'action Roivant Sciences d'ici là ?\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Avec l'\u003Cstrong>outil Modèle de Valorisation\u003C\u002Fstrong> de TIKR, vous pouvez estimer le cours potentiel d'une action en moins d'une minute.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Il suffit de trois entrées simples :\u003C\u002Fp>\n\n\n\n\u003Col class=\"wp-block-list\">\n\u003Cli>\u003Cem>Croissance du chiffre d'affaires\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Marges opérationnelles\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Multiple P\u002FE de sortie\u003C\u002Fem>\u003C\u002Fli>\n\u003C\u002Fol>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Si vous n'êtes pas sûr de quoi entrer, TIKR remplit automatiquement chaque entrée en utilisant les estimations consensus des analystes, vous donnant un point de départ rapide et fiable.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">À partir de là, TIKR calcule le cours potentiel de l'action et les rendements totaux selon des \u003Cstrong>scénarios Hausse, Base et Baisse\u003C\u002Fstrong> afin que vous puissiez rapidement voir si une action semble \u003Cstrong>sous-évaluée ou surévaluée\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Découvrez la vraie valeur d'une action en moins de 60 secondes (Gratuit avec TIKR) >>>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-looking-for-new-opportunities\" class=\"wp-block-heading\">À la recherche de nouvelles opportunités ?\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Découvrez quelles actions \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">les investisseurs milliardaires achètent\u003C\u002Fa> \u003C\u002Fstrong>pour suivre l'argent intelligent.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Analysez des actions en seulement 5 minutes\u003C\u002Fa>\u003C\u002Fstrong> avec la plateforme tout-en-un et facile à utiliser de TIKR.\u003C\u002Fli>\n\n\n\n\u003Cli>Plus vous retournez de pierres… plus vous découvrirez d'opportunités. \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Recherchez parmi 100K+ actions mondiales, les portefeuilles des meilleurs investisseurs mondiaux, et plus encore avec TIKR.\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Ch2 id=\"h-disclaimer\" class=\"wp-block-heading\">\u003Cstrong>Avertissement :\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>Veuillez noter que les articles sur TIKR ne sont pas destinés à servir de conseils en investissement ou financiers de la part de TIKR ou de notre équipe éditoriale, ni ne constituent des recommandations d'achat ou de vente d'actions. Nous créons notre contenu sur la base des données d'investissement du Terminal TIKR et des estimations des analystes. Notre analyse pourrait ne pas inclure des nouvelles récentes sur l'entreprise ou des mises à jour importantes. TIKR n'a aucune position sur les actions mentionnées. Merci de votre lecture et bon investissement !\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C\u002Fp>",763,"fr","\u002Fblog\u002Froivant-sciences-stock-rally-mosliciguat-phase-2-results","roivant-sciences-stock-rally-mosliciguat-phase-2-results","images\u002FROIV-tock\u002FROIV-tock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1788935569\u002Fimages\u002FROIV-tock\u002FROIV-tock.png?_i=AA",{"altText":165,"imageCredit":166},"Roivant Sciences Stock Rallies 20% On Positive Phase 2 Trial Results For Pulmovant Drug","@SUWANNAR KAWILA via Canva, @Artsanova from Getty Images via Canva",{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":172},"Aditya Raghunath","adityatikr","author","",[],{"name":174,"slug":175,"role":176,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":177},"David Hanson","davidtikr","editor",[],[179],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",0,[],{"title":165,"metaDesc":186,"opengraphDescription":186,"twitterTitle":165,"twitterDescription":186},"Roivant Sciences stock surges 22% after positive Phase 2 data for mosliciguat in PH-ILD, as Phase 3 trial enrollment begins.",{"title":165,"description":186,"twitterTitle":165,"twitterDescription":186,"author":168,"articlePublisher":188,"articlePublishedTime":154,"articleModifiedTime":155,"twitterLabel1":189,"twitterData1":190,"ogTitle":165,"ogDescription":186,"ogUrl":160,"ogImage":163,"ogImageWidth":191,"ogImageHeight":192,"ogImageSecureUrl":163,"ogImageAlt":165,"twitterImage":163},"TIKR.com","Temps de lecture estimé","6 minutes",1200,630,[194,208,225,240,255],{"id":183,"title":195,"date":196,"excerpt":197,"wordCount":198,"uri":199,"slug":200,"cloudinaryAssetId":-1,"featuredImageOriginalUrl":201,"featuredImageMetadata":202,"author":203,"categories":205,"relatedPosts":207},"L'action Lockheed Martin progresse après que UBS a rehaussé la note du constructeur de défense à \"Achat\" sur des perspectives de croissance des bénéfices solides","2026-09-09 10:41:00","UBS relève l'action Lockheed Martin à l'achat, citant la demande en missiles et la maintenance du F-35, avec un objectif de prix de 674 $ impliquant une hausse potentielle de 26 %.",805,"\u002Fblog\u002Flockheed-martin-lmt-stock-ubs-upgrade-buy-rating","lockheed-martin-lmt-stock-ubs-upgrade-buy-rating","https:\u002F\u002Ftikr1.wpengine.com\u002Fwp-content\u002Fuploads\u002F2026\u002F09\u002FLMT-stock-@Matt-Ragen-via-Canva-@tzahiV-from-Getty-Images-Signature-via-Canva-600x400.png",{"altText":195},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":204},[],[206],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":209,"date":210,"excerpt":211,"wordCount":212,"uri":213,"slug":214,"cloudinaryAssetId":215,"featuredImageOriginalUrl":216,"featuredImageMetadata":217,"author":218,"categories":222,"relatedPosts":224},"Ce que la hausse de 13% de DigitalOcean hier dit sur le *trade* d'inférence IA","2026-09-09 10:30:00","L'action DigitalOcean a bondi de 13 % en une seule séance sur la base d'un argumentaire lié à l'inférence d'IA, et l'objectif de prix de 175 $ de la Street se situe toujours 38 % au-dessus du nouveau cours de clôture.",1109,"\u002Fblog\u002Fwhat-digitaloceans-13-rally-yesterday-says-about-the-ai-inference-trade","what-digitaloceans-13-rally-yesterday-says-about-the-ai-inference-trade","images\u002FFEATURED-IMAGE-MAKER-1558\u002FFEATURED-IMAGE-MAKER-1558","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1788944207\u002Fimages\u002FFEATURED-IMAGE-MAKER-1558\u002FFEATURED-IMAGE-MAKER-1558.png?_i=AA",{"altText":209},{"name":219,"slug":220,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":221},"Gian Estrada","giantikr",[],[223],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":226,"date":227,"excerpt":228,"wordCount":229,"uri":230,"slug":231,"cloudinaryAssetId":232,"featuredImageOriginalUrl":233,"featuredImageMetadata":234,"author":235,"categories":237,"relatedPosts":239},"L'action Stryker chute de plus de 7 % alors que les contraintes de la chaîne d'approvisionnement impactent l'activité vasculaire périphérique","2026-09-09 10:21:00","L'action Stryker chute près de ses plus bas sur 52 semaines, les problèmes d'approvisionnement en matériel vasculaire périphérique et une demande orthopédique plus molle pesant sur la croissance, malgré des prévisions 2026 maintenues.",786,"\u002Fblog\u002Fstryker-stock-drops-peripheral-vascular-supply-constraints","stryker-stock-drops-peripheral-vascular-supply-constraints","images\u002FSYK-stock-@Mungkhoodstudios-Images-via-Canva-@PhonlamaiPhotos-Images-via-Canva\u002FSYK-stock-@Mungkhoodstudios-Images-via-Canva-@PhonlamaiPhotos-Images-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1788933931\u002Fimages\u002FSYK-stock-@Mungkhoodstudios-Images-via-Canva-@PhonlamaiPhotos-Images-via-Canva\u002FSYK-stock-@Mungkhoodstudios-Images-via-Canva-@PhonlamaiPhotos-Images-via-Canva.png?_i=AA",{"altText":226},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":236},[],[238],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":241,"date":242,"excerpt":243,"wordCount":244,"uri":245,"slug":246,"cloudinaryAssetId":247,"featuredImageOriginalUrl":248,"featuredImageMetadata":249,"author":250,"categories":252,"relatedPosts":254},"Voici la raison pour laquelle l'action Solaris Energy Infrastructure a bondi de 16 % hier.","2026-09-09 10:00:00","L'action Solaris Energy Infrastructure a bondi de 16,2 % mardi après une révision à la hausse de ses prévisions, liant 100 millions de dollars de nouvel EBITDA à la croissance de la demande énergétique des centres de données.",1338,"\u002Fblog\u002Fheres-the-reason-why-solaris-energy-infrastructure-stock-jumped-16-yesterday","heres-the-reason-why-solaris-energy-infrastructure-stock-jumped-16-yesterday","images\u002FFEATURED-IMAGE-MAKER-1557\u002FFEATURED-IMAGE-MAKER-1557","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1788943411\u002Fimages\u002FFEATURED-IMAGE-MAKER-1557\u002FFEATURED-IMAGE-MAKER-1557.png?_i=AA",{"altText":241},{"name":219,"slug":220,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":251},[],[253],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":256,"date":257,"excerpt":258,"wordCount":259,"uri":260,"slug":261,"cloudinaryAssetId":262,"featuredImageOriginalUrl":263,"featuredImageMetadata":264,"author":265,"categories":267,"relatedPosts":269},"L'action Novartis s'est effondrée de 11 % mardi. Deux essais cliniques infructueux sont en cause.","2026-09-09 09:30:00","L'action Novartis a chuté de 11 % en une seule séance, l'une de ses pires journées de négociation jamais enregistrées, après que l'essai du del-desiran n'a pas atteint son objectif principal dans la myotonie dystrophique.",1231,"\u002Fblog\u002Fnovartis-stock-crashed-11-on-tuesday-two-failed-trials-are-to-blame","novartis-stock-crashed-11-on-tuesday-two-failed-trials-are-to-blame","images\u002FFEATURED-IMAGE-MAKER-1556\u002FFEATURED-IMAGE-MAKER-1556","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1788942217\u002Fimages\u002FFEATURED-IMAGE-MAKER-1556\u002FFEATURED-IMAGE-MAKER-1556.png?_i=AA",{"altText":256},{"name":219,"slug":220,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":266},[],[268],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],[271,289,304,319,339,354,370,385,400,418,433,448,463],{"id":183,"title":272,"date":273,"excerpt":274,"wordCount":275,"uri":276,"slug":277,"cloudinaryAssetId":278,"featuredImageOriginalUrl":279,"featuredImageMetadata":280,"author":281,"categories":283,"relatedPosts":288},"Les résultats du deuxième trimestre de Waterdrop ont déclenché une hausse de 5%. L'histoire de la marge est plus complexe.","2026-09-09 09:00:00","Le chiffre d'affaires de Waterdrop a bondi de 73% au T2, mais le bénéfice net a reculé de 10% alors que les dépenses marketing ont triplé pour atteindre 638 millions de CNY. Que va-t-il se passer ensuite ?",870,"\u002Fblog\u002Fwaterdrops-q2-earnings-triggered-a-5-rally-the-margin-story-is-more-complicated","waterdrops-q2-earnings-triggered-a-5-rally-the-margin-story-is-more-complicated","images\u002FFEATURED-IMAGE-MAKER-1555\u002FFEATURED-IMAGE-MAKER-1555","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1788936003\u002Fimages\u002FFEATURED-IMAGE-MAKER-1555\u002FFEATURED-IMAGE-MAKER-1555.png?_i=AA",{"altText":272},{"name":219,"slug":220,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":282},[],[284],{"name":285,"slug":286,"uri":287,"description":171,"postsCount":183},"Mises à Jour des Résultats","earnings-updates","\u002Fblog\u002Fcategory\u002Fearnings-updates",[],{"id":183,"title":290,"date":291,"excerpt":292,"wordCount":293,"uri":294,"slug":295,"cloudinaryAssetId":296,"featuredImageOriginalUrl":297,"featuredImageMetadata":298,"author":299,"categories":301,"relatedPosts":303},"L'action Braze a chuté de 5 % après les résultats du T2, malgré un dépassement sur tous les indicateurs. Voici pourquoi.","2026-09-09 08:30:00","L'action Braze a chuté de 13 % après les résultats du T2, tombant à 26,40 $ en after-hours, avant de récupérer la majeure partie de ses pertes, pour finir à seulement 5 % en dessous de sa clôture à 30,31 $.",982,"\u002Fblog\u002Fbraze-stock-fell-5-after-q2-earnings-even-with-a-beat-on-every-line-heres-why","braze-stock-fell-5-after-q2-earnings-even-with-a-beat-on-every-line-heres-why","images\u002FFEATURED-IMAGE-MAKER-1554\u002FFEATURED-IMAGE-MAKER-1554","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1788934578\u002Fimages\u002FFEATURED-IMAGE-MAKER-1554\u002FFEATURED-IMAGE-MAKER-1554.png?_i=AA",{"altText":290},{"name":219,"slug":220,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":300},[],[302],{"name":285,"slug":286,"uri":287,"description":171,"postsCount":183},[],{"id":183,"title":305,"date":306,"excerpt":307,"wordCount":308,"uri":309,"slug":310,"cloudinaryAssetId":311,"featuredImageOriginalUrl":312,"featuredImageMetadata":313,"author":314,"categories":316,"relatedPosts":318},"Les résultats du deuxième trimestre de ServiceTitan surpassent toutes les estimations. Alors pourquoi l'action a-t-elle chuté de 7 % après ?","2026-09-09 08:00:00","ServiceTitan a dépassé les prévisions de revenus du T2 de 2,38 % et le BPA ajusté de 14,23 %, pourtant l'action TTAN a encore chuté de 7,21 % le jour de bourse suivant.",1085,"\u002Fblog\u002Fservicetitans-q2-earnings-beat-every-estimate-so-why-did-the-stock-fell-7-after","servicetitans-q2-earnings-beat-every-estimate-so-why-did-the-stock-fell-7-after","images\u002FFEATURED-IMAGE-MAKER-1552_1295605c1e8\u002FFEATURED-IMAGE-MAKER-1552_1295605c1e8","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1788930384\u002Fimages\u002FFEATURED-IMAGE-MAKER-1552_1295605c1e8\u002FFEATURED-IMAGE-MAKER-1552_1295605c1e8.png?_i=AA",{"altText":305},{"name":219,"slug":220,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":315},[],[317],{"name":285,"slug":286,"uri":287,"description":171,"postsCount":183},[],{"id":183,"title":320,"date":321,"excerpt":322,"wordCount":323,"uri":324,"slug":325,"cloudinaryAssetId":326,"featuredImageOriginalUrl":327,"featuredImageMetadata":328,"author":329,"categories":333,"relatedPosts":338},"L'action Amgen a chuté de 9,6 % après l'échec de l'essai de Novartis et une suspension de Tavneos","2026-09-09 07:20:00","Voici pourquoi l'action Amgen a chuté de 9,6 % cette semaine après qu'un échec d'essai de Novartis et une suspension d'un médicament au Royaume-Uni sont entrés en collision.",1171,"\u002Fblog\u002Famgen-stock-sank-9-6-after-novartiss-trial-failure-and-a-tavneos-suspension","amgen-stock-sank-9-6-after-novartiss-trial-failure-and-a-tavneos-suspension","images\u002FAMGN-stock_129416379a4\u002FAMGN-stock_129416379a4","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1788884817\u002Fimages\u002FAMGN-stock_129416379a4\u002FAMGN-stock_129416379a4.png?_i=AA",{"altText":320},{"name":330,"slug":331,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":332},"Rexielyn Diaz","rexietikr",[],[334],{"name":335,"slug":336,"uri":337,"description":171,"postsCount":183},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",[],{"id":183,"title":340,"date":341,"excerpt":342,"wordCount":343,"uri":344,"slug":345,"cloudinaryAssetId":346,"featuredImageOriginalUrl":347,"featuredImageMetadata":348,"author":349,"categories":351,"relatedPosts":353},"L'action Domino's a chuté de 27 % par rapport à son plus haut sur 52 semaines. Voici pourquoi","2026-09-09 07:00:00","Voici pourquoi l'action Domino's a fortement reculé par rapport à ses sommets, alors même que ses rivaux Pizza Hut et Papa John's sont en plus grande difficulté.",1162,"\u002Fblog\u002Fdominos-stock-has-fallen-27-from-its-52-week-high-heres-why","dominos-stock-has-fallen-27-from-its-52-week-high-heres-why","images\u002FDPZ-stock-1_129415149e0\u002FDPZ-stock-1_129415149e0","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1788884634\u002Fimages\u002FDPZ-stock-1_129415149e0\u002FDPZ-stock-1_129415149e0.png?_i=AA",{"altText":340},{"name":330,"slug":331,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":350},[],[352],{"name":335,"slug":336,"uri":337,"description":171,"postsCount":183},[],{"id":183,"title":355,"date":356,"excerpt":357,"wordCount":358,"uri":359,"slug":360,"cloudinaryAssetId":361,"featuredImageOriginalUrl":362,"featuredImageMetadata":363,"author":365,"categories":367,"relatedPosts":369},"P&G mise 3,8 milliards de dollars sur le bien-être. Peut-il compenser un facteur défavorable de coût d'un milliard de dollars ?","2026-09-09 06:40:00","Voici pourquoi l'action P&G est restée calme alors que les investisseurs pèsent l'acquisition de Thorne face aux facteurs défavorables liés à la hausse des coûts.",1201,"\u002Fblog\u002Fpg-is-betting-3-8-billion-on-wellness-can-it-offset-a-1-billion-cost-headwind","pg-is-betting-3-8-billion-on-wellness-can-it-offset-a-1-billion-cost-headwind","images\u002FPG-stock_1294141535e\u002FPG-stock_1294141535e","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1788884530\u002Fimages\u002FPG-stock_1294141535e\u002FPG-stock_1294141535e.png?_i=AA",{"altText":364},"P&G mise 3,8 milliards de dollars sur le bien-être. Peut-il compenser un facteur défavorable de coût d'un milliard de dollars ?",{"name":330,"slug":331,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":366},[],[368],{"name":335,"slug":336,"uri":337,"description":171,"postsCount":183},[],{"id":183,"title":371,"date":372,"excerpt":373,"wordCount":374,"uri":375,"slug":376,"cloudinaryAssetId":377,"featuredImageOriginalUrl":378,"featuredImageMetadata":379,"author":380,"categories":382,"relatedPosts":384},"L'action d'Atlassian a chuté de 5 % malgré une hausse de 44 % des commandes non exécutées (RPO) à 4,8 milliards de dollars.","2026-09-09 06:20:00","Voici pourquoi l'action Atlassian a chuté de 5 % cette semaine malgré un trimestre exceptionnel et une croissance fulgurante du cloud.",1158,"\u002Fblog\u002Fatlassian-stock-slid-5-despite-rpo-surging-44-to-4-8-billion","atlassian-stock-slid-5-despite-rpo-surging-44-to-4-8-billion","images\u002FTEAM-stock_129413d289c\u002FTEAM-stock_129413d289c","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1788884376\u002Fimages\u002FTEAM-stock_129413d289c\u002FTEAM-stock_129413d289c.png?_i=AA",{"altText":371},{"name":330,"slug":331,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":381},[],[383],{"name":335,"slug":336,"uri":337,"description":171,"postsCount":183},[],{"id":183,"title":386,"date":387,"excerpt":388,"wordCount":389,"uri":390,"slug":391,"cloudinaryAssetId":392,"featuredImageOriginalUrl":393,"featuredImageMetadata":394,"author":395,"categories":397,"relatedPosts":399},"L'action Dell progresse de 15 % cette semaine alors que son carnet de commandes IA atteint 95 milliards de dollars","2026-09-09 06:00:00","Voici pourquoi l'action Dell a bondi de 15 % cette semaine après que les commandes de serveurs IA ont atteint un carnet de commandes record de 95 milliards de dollars.",1233,"\u002Fblog\u002Fdell-stock-is-up-15-this-week-as-its-ai-backlog-hits-95-billion","dell-stock-is-up-15-this-week-as-its-ai-backlog-hits-95-billion","images\u002FDELL-stock_129412eec92\u002FDELL-stock_129412eec92","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1788884229\u002Fimages\u002FDELL-stock_129412eec92\u002FDELL-stock_129412eec92.png?_i=AA",{"altText":386},{"name":330,"slug":331,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":396},[],[398],{"name":335,"slug":336,"uri":337,"description":171,"postsCount":183},[],{"id":183,"title":401,"date":402,"excerpt":403,"wordCount":404,"uri":405,"slug":406,"cloudinaryAssetId":407,"featuredImageOriginalUrl":408,"featuredImageMetadata":409,"author":410,"categories":412,"relatedPosts":417},"En baisse de 35 % en 2026, l'action Intuitive Surgical peut-elle se redresser d'ici 2028 ?","2026-09-08 15:42:33","ISRG cotise près de 367 $ après un ralentissement des procédures aux États-Unis. Consultez le modèle d'évaluation de TIKR, ses hypothèses clés et ses scénarios haussier\u002Fde base\u002Fbaissier.",1113,"\u002Fblog\u002Fintuitive-surgical-isrg-stock-valuation-2028-forecast","intuitive-surgical-isrg-stock-valuation-2028-forecast","images\u002FISRG-stock-@PhonlamaiPhotos-Images-via-Canva-@freedomz-via-Canva\u002FISRG-stock-@PhonlamaiPhotos-Images-via-Canva-@freedomz-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1788864551\u002Fimages\u002FISRG-stock-@PhonlamaiPhotos-Images-via-Canva-@freedomz-via-Canva\u002FISRG-stock-@PhonlamaiPhotos-Images-via-Canva-@freedomz-via-Canva.png?_i=AA",{"altText":401},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":411},[],[413],{"name":414,"slug":415,"uri":416,"description":171,"postsCount":183},"Évaluation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":183,"title":419,"date":420,"excerpt":421,"wordCount":422,"uri":423,"slug":424,"cloudinaryAssetId":425,"featuredImageOriginalUrl":426,"featuredImageMetadata":427,"author":428,"categories":430,"relatedPosts":432},"En hausse modeste sur les 12 derniers mois, l'action Exelon peut-elle offrir davantage d'ici 2028 ?","2026-09-08 15:42:00","EXC se négocie près de 44 $ alors que les tensions sur le réseau PJM augmentent. Consultez le modèle de valorisation de TIKR, les hypothèses clés et les scénarios haussier\u002Fneutre\u002Fbaissier pour l'action Exelon.",1169,"\u002Fblog\u002Fexelon-exc-stock-valuation-2028-forecast","exelon-exc-stock-valuation-2028-forecast","images\u002FEXC-stock-@Yelantsevv-from-Getty-Images-via-Canva-@Krasnikova-Ekaterina-from-Изображения-пользователя-Kathleen-via-Canva\u002FEXC-stock-@Yelantsevv-from-Getty-Images-via-Canva-@Krasnikova-Ekaterina-from-Изображения-пользователя-Kathleen-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1788866401\u002Fimages\u002FEXC-stock-@Yelantsevv-from-Getty-Images-via-Canva-@Krasnikova-Ekaterina-from-Изображения-пользователя-Kathleen-via-Canva\u002FEXC-stock-@Yelantsevv-from-Getty-Images-via-Canva-@Krasnikova-Ekaterina-from-Изображения-пользователя-Kathleen-via-Canva.png?_i=AA",{"altText":419},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":429},[],[431],{"name":414,"slug":415,"uri":416,"description":171,"postsCount":183},[],{"id":183,"title":434,"date":435,"excerpt":436,"wordCount":437,"uri":438,"slug":439,"cloudinaryAssetId":440,"featuredImageOriginalUrl":441,"featuredImageMetadata":442,"author":443,"categories":445,"relatedPosts":447},"En baisse de 39% sur les 12 derniers mois, l'action Norwegian Cruise Line peut-elle se redresser d'ici 2028 ?","2026-09-08 15:41:19","NCLH cotise autour de 16 $ en plein redressement. Consultez le modèle de valorisation de TIKR, les hypothèses clés et les scénarios haussier\u002Fbase\u002Fbaissier pour Norwegian Cruise Line.",1095,"\u002Fblog\u002Fnorwegian-cruise-line-nclh-stock-valuation-2028-forecast","norwegian-cruise-line-nclh-stock-valuation-2028-forecast","images\u002FNCLH-stock-@elijah.lovkoffs-Images-via-Canva-@Kelly-from-Pexels-via-Canva\u002FNCLH-stock-@elijah.lovkoffs-Images-via-Canva-@Kelly-from-Pexels-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1788868316\u002Fimages\u002FNCLH-stock-@elijah.lovkoffs-Images-via-Canva-@Kelly-from-Pexels-via-Canva\u002FNCLH-stock-@elijah.lovkoffs-Images-via-Canva-@Kelly-from-Pexels-via-Canva.png?_i=AA",{"altText":434},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":444},[],[446],{"name":414,"slug":415,"uri":416,"description":171,"postsCount":183},[],{"id":183,"title":449,"date":450,"excerpt":451,"wordCount":452,"uri":453,"slug":454,"cloudinaryAssetId":455,"featuredImageOriginalUrl":456,"featuredImageMetadata":457,"author":458,"categories":460,"relatedPosts":462},"En baisse de 31% sur les 12 derniers mois, l'action Pegasystems peut-elle se redresser d'ici 2028 ?","2026-09-08 15:40:50","PEGA se négocie près de 37 $ après une croissance lente de l'ACV. Consultez le modèle d'évaluation de TIKR, les hypothèses clés et les scénarios haussier\u002Fneutre\u002Fbaissier pour l'action Pegasystems.",1112,"\u002Fblog\u002Fpegasystems-pega-stock-valuation-2028-forecast","pegasystems-pega-stock-valuation-2028-forecast","images\u002FPEGA-stock-@metamorworks-from-Getty-Images-via-Canva-@AndreyPopov-from-Getty-Images-Signature-via-Canva\u002FPEGA-stock-@metamorworks-from-Getty-Images-via-Canva-@AndreyPopov-from-Getty-Images-Signature-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1788872863\u002Fimages\u002FPEGA-stock-@metamorworks-from-Getty-Images-via-Canva-@AndreyPopov-from-Getty-Images-Signature-via-Canva\u002FPEGA-stock-@metamorworks-from-Getty-Images-via-Canva-@AndreyPopov-from-Getty-Images-Signature-via-Canva.png?_i=AA",{"altText":449},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":459},[],[461],{"name":414,"slug":415,"uri":416,"description":171,"postsCount":183},[],{"id":183,"title":464,"date":465,"excerpt":466,"wordCount":467,"uri":468,"slug":469,"cloudinaryAssetId":470,"featuredImageOriginalUrl":471,"featuredImageMetadata":472,"author":473,"categories":475,"relatedPosts":477},"En baisse de 19% par rapport à ses sommets, l'action Toast peut-elle tenir ses promesses d'ici 2028 ?","2026-09-08 11:55:00","TOST se négocie près de 34 $ après un trimestre record de croissance du nombre de points de vente. Consultez le modèle d'évaluation de TIKR, ses hypothèses clés et ses scénarios haussier\u002Fbase\u002Fbaissier.",1101,"\u002Fblog\u002Ftoast-tost-stock-valuation-2028-forecast","toast-tost-stock-valuation-2028-forecast","images\u002FTOST-stock-@alengo-from-Getty-Images-Signature-via-Canva-@dogayusufdokdok-from-Getty-Images-Signature-via-Canva\u002FTOST-stock-@alengo-from-Getty-Images-Signature-via-Canva-@dogayusufdokdok-from-Getty-Images-Signature-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1788862389\u002Fimages\u002FTOST-stock-@alengo-from-Getty-Images-Signature-via-Canva-@dogayusufdokdok-from-Getty-Images-Signature-via-Canva\u002FTOST-stock-@alengo-from-Getty-Images-Signature-via-Canva-@dogayusufdokdok-from-Getty-Images-Signature-via-Canva.png?_i=AA",{"altText":464},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":474},[],[476],{"name":414,"slug":415,"uri":416,"description":171,"postsCount":183},[]]